SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-122796
Filing Date
2018-04-19
Accepted
2018-04-19 17:12:02
Documents
7
Effectiveness Date
2018-04-19

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A d585275ddefa14a.htm DEFA14A 32224
2 GRAPHIC g585275g05e15.jpg GRAPHIC 23408
3 GRAPHIC g585275g16q56.jpg GRAPHIC 13701
4 GRAPHIC g585275g48k66.jpg GRAPHIC 28639
5 GRAPHIC g585275g62d05.jpg GRAPHIC 24728
6 GRAPHIC g585275g76c99.jpg GRAPHIC 32714
7 GRAPHIC g585275g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-18-122796.txt   221480
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEFA14A | Act: 34 | File No.: 001-37695 | Film No.: 18764494
SIC: 2834 Pharmaceutical Preparations